Respiratory syncytial virus activates innate immunity through Toll-like receptor 2. - Wikidata - wikimedia - TriplyDB

Respiratory syncytial virus activates innate immunity through Toll-like receptor 2.

Respiratory syncytial virus activates innate immunity through Toll-like receptor 2.

http://www.wikidata.org/entity/Q37051620

about

In Hot Pursuit of the First Vaccine Against Respiratory Syncytial Virus Toll-like receptors: key players in antiviral immunity Toll-like receptors in antiviral innate immunity The innate immune system of the perinatal lung and responses to respiratory syncytial virus infection Induction of protective effector immunity to prevent pathogenesis caused by the respiratory syncytial virus. Implications on therapy and vaccine design Modulation of host adaptive immunity by hRSV proteins Critical role of TLR4 in human metapneumovirus mediated innate immune responses and disease pathogenesis Phylodynamics and dispersal of HRSV entails its permanence in the general population in between yearly outbreaks in children Respiratory viral infections and host responses; insights from genomics Space and time: New considerations about the relationship between Toll-like receptors (TLRs) and type I interferons (IFNs)A novel 5-lipoxygenase-activating protein inhibitor, AM679, reduces inflammation in the respiratory syncytial virus-infected mouse eye A Role for Neutrophils in Viral Respiratory Disease.Respiratory syncytial virus infection induces higher Toll-like receptor-3 expression and TNF-α production than human metapneumovirus infection Evasion by stealth: inefficient immune activation underlies poor T cell response and severe disease in SARS-CoV-infected mice.Newcastle disease virus-like particles containing respiratory syncytial virus G protein induced protection in BALB/c mice, with no evidence of immunopathology.Respiratory viral infections in infants: causes, clinical symptoms, virology, and immunology.Discovery of a novel TLR2 signaling inhibitor with anti-viral activity.TLR4 Asp299Gly and Thr399Ile polymorphisms: no impact on human immune responsiveness to LPS or respiratory syncytial virus Anti-inflammatory effect of MUC1 during respiratory syncytial virus infection of lung epithelial cells in vitro.Rhinovirus-induced macrophage cytokine expression does not require endocytosis or replication Assembly and biological and immunological properties of Newcastle disease virus-like particles.Toll-like receptor 2-mediated innate immune responses against Junín virus in mice lead to antiviral adaptive immune responses during systemic infection and do not affect viral replication in the brain Activation of interferon response through toll-like receptor 3 impacts viral pathogenesis and pulmonary toll-like receptor expression during respiratory syncytial virus and influenza infections in the cotton rat Sigmodon hispidus model.Schistosoma japonicum infection induces macrophage polarization.Prenatal maternal stress and cord blood innate and adaptive cytokine responses in an inner-city cohort.Modification of the respiratory syncytial virus f protein in virus-like particles impacts generation of B cell memory.CD14 deficiency impacts glucose homeostasis in mice through altered adrenal tone.TLR2/MyD88/NF-κB pathway, reactive oxygen species, potassium efflux activates NLRP3/ASC inflammasome during respiratory syncytial virus infection Innate immune recognition of respiratory syncytial virus infection.New insights for development of a safe and protective RSV vaccine Decreased Toll-like receptor 8 expression and lower TNF-α synthesis in infants with acute RSV infection Quantitative proteomic analysis of A549 cells infected with human respiratory syncytial virus The airway epithelium: soldier in the fight against respiratory viruses HIV-1 Tat protein binds to TLR4-MD2 and signals to induce TNF-α and IL-10.Evaluation of an intranasal virosomal vaccine against respiratory syncytial virus in mice: effect of TLR2 and NOD2 ligands on induction of systemic and mucosal immune responses.Reprogramming of murine macrophages through TLR2 confers viral resistance via TRAF3-mediated, enhanced interferon production.Nasally administered Lactobacillus rhamnosus strains differentially modulate respiratory antiviral immune responses and induce protection against respiratory syncytial virus infection Kaposi's sarcoma-associated herpesvirus-encoded replication and transcription activator impairs innate immunity via ubiquitin-mediated degradation of myeloid differentiation factor 88 Novel drugs targeting Toll-like receptors for antiviral therapy.Respiratory syncytial virus induced type I IFN production by pDC is regulated by RSV-infected airway epithelial cells, RSV-exposed monocytes and virus specific antibodies

P2860

Q26748856-E51F2D7E-C5F5-48D4-8649-0E3C3932D858 Q26865983-B0B0DED4-DAA2-40D2-9262-4AC66E42A67F Q27011462-3F422F82-6DE3-49CA-9798-59DEBBFFEF14 Q27011872-5B1DFDF8-D8AA-4937-BC05-7C4EE587F355 Q27021304-BF9D6234-7511-47C6-B29B-974B28358772 Q27022693-6BD7369E-DA70-4011-A8B8-338811A3850D Q27302959-2A1203E1-7028-4862-8AA0-893E51B1BAAE Q27329785-80B7371F-33BA-466E-B106-9433D21DDB91 Q28079922-6833A44E-B841-41A8-B145-AB8857D2D043 Q28081328-99EEC6B6-4119-4E0B-AE37-07B44F9574E3 Q28258798-CDB2FD28-AAEF-4EE6-B558-73815355F0FF Q30234336-F3877243-357D-4B91-895A-6C2C057D366A Q31139109-F6B00F1D-0E29-4E04-B3D0-7D93CCC2F745 Q33511964-D3455ACA-9F93-470F-AC6C-378DCFA839C5 Q33558475-02C3E5F2-0270-413B-98CC-25CE88B214E2 Q33591243-70A9E47F-CD8B-4068-8A6B-C9F4E663C36B Q33625617-7C54A820-71BF-4AFA-98F3-E16F49FA72B8 Q33658939-324557E4-CFB8-4E4E-9026-D9F7C6728A4A Q33784124-5054CD5A-DD23-482E-A84C-67368F752024 Q33799737-DD4B400C-C093-4818-A171-5A07389ED8E6 Q33826688-62A1CA98-2778-4642-9803-64FBD38136EE Q33900343-D8DEC2BF-D36D-415D-B816-23AC723C4D00 Q33901537-69C3972C-F243-41C1-85E1-4C6054FFFDF9 Q33917757-BD0C9DA4-8160-414C-BB72-7BE63398BCEA Q33988118-082456E2-D488-403D-8B68-185CC05709A0 Q34059404-05DBEB57-1334-40D0-8F41-8F58D2AB43C6 Q34130570-916E5588-089C-4368-B0B9-7FDEF0864C88 Q34147516-1932201F-1776-4B9E-8DDA-05CD6C53C547 Q34180049-0D46213D-C2C6-4F67-86C3-AF314D9657C4 Q34249859-E060F9FF-A6EB-4AC5-B3E9-CE6DF0CDC5AC Q34282702-248FC0EA-D1AF-435F-9BF5-3B9049510578 Q34320755-4EF0A0BA-62E0-4698-9C00-2A733D3D8230 Q34491598-56125EF0-D950-4F6C-82F2-AC822D9C7BBD Q34508575-FEA86087-500B-416E-9AD5-D3EEDE1B719D Q34674831-215C8CF6-74C8-4705-975C-8EE793C8B113 Q34819672-A551B47B-EB9B-4886-8970-506F265145BB Q34943083-BBD26ECF-FAEC-4C12-B750-472ED4A9984A Q34992629-3844B063-C022-463E-A44F-04CE80D518D7 Q34999938-8B9217F9-064A-4F0D-A8E6-8A9B608D1F16 Q35058641-85875DA4-105F-49B8-8769-703CAD9EB45B

P2860

Respiratory syncytial virus activates innate immunity through Toll-like receptor 2.

http://www.wikidata.org/entity/Q37051620

description

2008 nî lūn-bûn

@nan

2008年の論文

@ja

2008年学术文章

@wuu

2008年学术文章

@zh-cn

2008年学术文章

@zh-hans

2008年学术文章

@zh-my

2008年学术文章

@zh-sg

2008年學術文章

@yue

2008年學術文章

@zh

2008年學術文章

@zh-hant

name

Respiratory syncytial virus activates innate immunity through Toll-like receptor 2.

@en

Respiratory syncytial virus activates innate immunity through Toll-like receptor 2.

@nl

type

label

Respiratory syncytial virus activates innate immunity through Toll-like receptor 2.

@en

Respiratory syncytial virus activates innate immunity through Toll-like receptor 2.

@nl

prefLabel

Respiratory syncytial virus activates innate immunity through Toll-like receptor 2.

@en

Respiratory syncytial virus activates innate immunity through Toll-like receptor 2.

@nl

P1433

Q37051620-0B8D59C9-B51C-40C8-90AC-3EB6BE0D39EF

P1476

Q37051620-4C776A15-C0E5-4D06-929A-BAACFB6669E0

P2093

Q37051620-137D93E9-4943-4E2D-975E-9351A5B491E8

Q37051620-262B2665-EEA3-4CA1-9027-3A5C95927420

Q37051620-633A737E-EB77-4C71-9B35-EB3054ACEFEE

Q37051620-64052CE0-47EF-42E2-8B81-3DB4BD8FB7F7

Q37051620-A4F5653D-7969-412A-A3F6-5B717B72DD51

Q37051620-AEFCBF81-8B2A-4D56-81D7-65E42A3983DF

Q37051620-BDBC0E30-7F5F-46CC-9580-FA07B7D2E782

Q37051620-C0C71A83-104B-4343-9500-37887AAAD0A2

P2860

Q37051620-03904A4C-BABD-4C93-B308-5B6B2367472B

Q37051620-0B74580E-6340-475A-BE58-62CCD77AA6FB

Q37051620-0E24F0A1-6D16-4F1E-94E6-66A8CF68F764

Q37051620-20978952-2ACF-431A-A620-DB001282DF0C

Q37051620-209FDB10-9270-49AA-831D-BDB78254ABA6

Q37051620-20EF7F8A-B694-4968-AC92-84FA0D78B205

Q37051620-246AFF5D-8090-4CF5-8E1A-527FB89F4D36

Q37051620-249CFEA0-2DC3-4862-A765-6C3315D500B6

Q37051620-2A777277-5EC8-40B2-964B-9FCFBBE2F584

Q37051620-35607FF4-1E57-47A4-AF4B-8047A7EA4D23

P304

Q37051620-5E40BCD4-8CDD-4633-AE26-957541E0E82A

P31

Q37051620-F8E506A0-D1C5-4BCE-B9E7-45B50113C3D2

P356

Q37051620-1FFCF03C-58BC-48E3-8100-4697D83E3723

P407

Q37051620-B0D29570-2008-4CE4-A4D5-0CBA3A34F3E8

P433

Q37051620-44A855B6-0BCA-4E01-B2C8-937BC861F37C

P478

Q37051620-B4094A75-1C43-49B1-85D3-B75C925288A5

P577

Q37051620-2045E015-BB62-4172-9D5F-A4AAE557C0D9

P5875

Q37051620-228555B5-0D5A-4C91-9707-CD8C9564AE4B

P698

Q37051620-51257225-EA29-4D1B-A50D-3C960B3F4E0B

P921

Q37051620-4C6E3A69-C959-4EB1-9B5A-44CFAC50D7B2

P932

Q37051620-7C3B518A-A69A-478C-B9C6-4D093796551A

P356

P1433

Journal of Virology

P1476

Respiratory syncytial virus activates innate immunity through Toll-like receptor 2.

@en

P2093

Anna M Cerny

http://www.w3.org/2001/XMLSchema#string

Evelyn A Kurt-Jones

http://www.w3.org/2001/XMLSchema#string

Glennice N Bowen

http://www.w3.org/2001/XMLSchema#string

Larry J Anderson

http://www.w3.org/2001/XMLSchema#string

Lia M Haynes

http://www.w3.org/2001/XMLSchema#string

Matthew R Murawski

http://www.w3.org/2001/XMLSchema#string

Ralph A Tripp

http://www.w3.org/2001/XMLSchema#string

Robert W Finberg

http://www.w3.org/2001/XMLSchema#string

P2860

Pathogen recognition and innate immunity

Cutting edge: a novel Toll/IL-1 receptor domain-containing adapter that preferentially activates the IFN-beta promoter in the Toll-like receptor signaling

Toll-like receptor control of the adaptive immune responses

Neutrophil survival is prolonged in the airways of healthy infants and infants with RSV bronchiolitis.

Involvement of toll-like receptor 4 in innate immunity to respiratory syncytial virus.

The interaction of neutrophils with respiratory epithelial cells in viral infection.

Murine retroviruses activate B cells via interaction with toll-like receptor 4

Differential chemokine expression following respiratory virus infection reflects Th1- or Th2-biased immunopathology.

Human cytomegalovirus activates inflammatory cytokine responses via CD14 and Toll-like receptor 2.

Links between respiratory syncytial virus bronchiolitis and childhood asthma: clinical and research approaches.

P304

1492-1500

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/JVI.00671-08

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

83

http://www.w3.org/2001/XMLSchema#string

P577

2008-11-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

23484043

http://www.w3.org/2001/XMLSchema#string

P698

19019963

http://www.w3.org/2001/XMLSchema#string

P921

Toll-like receptor

P932

2620898

http://www.w3.org/2001/XMLSchema#string